BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3014412)

  • 1. Intraocular 9-([2-hydroxy-1-(hydroxymethyl) ethoxy] methyl) guanine levels after intravitreal and subconjunctival administration.
    Schulman J; Peyman GA; Horton MB; Liu J; Fiscella R; Pulido J; Barber JC; de Miranda P
    Ophthalmic Surg; 1986 Jul; 17(7):429-32. PubMed ID: 3014412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular penetration of new antiviral agent, hydroxyacyclovir (BW-B759U).
    Schulman J; Peyman GA; Horton MB; Liu J; Barber JC; Fiscella R; de Miranda P
    Jpn J Ophthalmol; 1986; 30(1):116-24. PubMed ID: 3014189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS.
    Henry K; Cantrill H; Fletcher C; Chinnock BJ; Balfour HH
    Am J Ophthalmol; 1987 Jan; 103(1):17-23. PubMed ID: 3026186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal ganciclovir in CMV retinitis: case report.
    Harris ML; Mathalone MB
    Br J Ophthalmol; 1989 May; 73(5):382-4. PubMed ID: 2543438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine.
    Felsenstein D; D'Amico DJ; Hirsch MS; Neumeyer DA; Cederberg DM; de Miranda P; Schooley RT
    Ann Intern Med; 1985 Sep; 103(3):377-80. PubMed ID: 2992334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal pharmacokinetics and retinal concentrations of ganciclovir and foscarnet after intravitreal administration in rabbits.
    López-Cortés LF; Pastor-Ramos MT; Ruiz-Valderas R; Cordero E; Uceda-Montañés A; Claro-Cala CM; Lucero-Muñoz MJ
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1024-8. PubMed ID: 11274081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS.
    Maurice DM
    Am J Ophthalmol; 1987 Jun; 103(6):842-3. PubMed ID: 3035928
    [No Abstract]   [Full Text] [Related]  

  • 8. Ocular complications of the acquired immunodeficiency syndrome.
    Nussenblatt R
    Nat Immun Cell Growth Regul; 1988; 7(3):131-4. PubMed ID: 2845260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release kinetics of liposome-encapsulated ganciclovir after intravitreal injection in rabbits.
    Le Bourlais C; Chevanne F; Ropert P; Bretagne G; Acar L; Zia H; Sado PA; Needham T; Leverge R
    J Microencapsul; 1996; 13(4):473-80. PubMed ID: 8808783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intraocular penetration of acyclovir after subconjunctival administration.
    Schulman J; Peyman GA; Liu J; Scott M; Barber JC
    Ophthalmic Surg; 1987 Feb; 18(2):111-4. PubMed ID: 3574863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation.
    Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Keefe KS; Bergeron-Lynn G; Severson GM; Soules KA; Mueller AJ; Freeman WR
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1523-32. PubMed ID: 10798672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraocular dexamethasone penetration via subconjunctival or retrobulbar injections in rabbits.
    Bodker FS; Ticho BH; Feist RM; Lam TT
    Ophthalmic Surg; 1993 Jul; 24(7):453-7. PubMed ID: 8351091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term intravitreal ganciclovir for cytomegalovirus retinitis in a patient with AIDS. Case report.
    Büchi ER; Fitting PL; Michel AE
    Arch Ophthalmol; 1988 Oct; 106(10):1349-50. PubMed ID: 2845902
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of viral retinitis.
    Schulman JA; Peyman GA
    Ophthalmic Surg; 1988 Dec; 19(12):876-84. PubMed ID: 2852786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular acyclovir levels after subconjunctival and topical administration.
    Schulman J; Peyman GA; Fiscella R; Greenberg D; Horton MB; de Miranda P
    Br J Ophthalmol; 1986 Feb; 70(2):138-40. PubMed ID: 3947611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis.
    Ussery FM; Gibson SR; Conklin RH; Piot DF; Stool EW; Conklin AJ
    Ophthalmology; 1988 May; 95(5):640-8. PubMed ID: 2845321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results.
    Cantrill HL; Henry K; Melroe NH; Knobloch WH; Ramsay RC; Balfour HH
    Ophthalmology; 1989 Mar; 96(3):367-74. PubMed ID: 2540470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganciclovir.
    Med Lett Drugs Ther; 1989 Aug; 31(799):79-80. PubMed ID: 2549352
    [No Abstract]   [Full Text] [Related]  

  • 19. Intraocular penetration of topically administered acyclovir.
    Kitagawa K; Fukuda M; Sasaki K
    Lens Eye Toxic Res; 1989; 6(1-2):365-73. PubMed ID: 2488028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of cytomegalovirus retinitis with dihydroxypropoxymethylguanine in a patient with acquired immunodeficiency syndrome].
    Guelar A; Grau J; Buil JA; Castilla M
    Med Clin (Barc); 1987 Oct; 89(10):439-40. PubMed ID: 2824940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.